{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Amylyx Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"AMLX"},"Address":{"label":"Address","value":"43 THORNDIKE STREET, CAMBRIDGE, Massachusetts, 02141, United States"},"Phone":{"label":"Phone","value":"+1 617 682-0917"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.amylyx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Camille L. Bedrosian","title":"Chief Medical Officer"},{"name":"Joshua B. Cohen","title":"Co-Chief Executive Officer & Executive Director"},{"name":"Justin Klee","title":"Co-Chief Executive Officer & Executive Director"},{"name":"Tom Holmes","title":"Chief Technical Operations Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}